Advagene Biopharma Co., Ltd. (TPEX:6709)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
28.35
+2.00 (7.59%)
Jan 22, 2026, 1:52 PM CST
35.65%
Market Cap1.56B
Revenue (ttm)n/a
Net Income (ttm)-71.10M
Shares Out59.38M
EPS (ttm)-1.23
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume181,218
Average Volume47,808
Open26.50
Previous Close26.35
Day's Range26.35 - 29.25
52-Week Range15.75 - 41.00
Beta0.67
RSI38.99
Earnings DateMar 20, 2026

About Advagene Biopharma

Advagene Biopharma Co., Ltd. engages in the research and development of vaccine technology and related products in Taiwan. It engages in the development of nasal spray influenza vaccine; respiratory allergy treatment vaccine, including rhinitis and asthma; COVID-19 immunotherapy; and other vaccines. The company was founded in 2006 and is based in Taipei, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2006
Employees 12
Stock Exchange Taipei Exchange
Ticker Symbol 6709
Full Company Profile

Financial Performance

Financial Statements